# OnCo record nct03526835 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct03526835/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct03526835", "NCT03526835" ;
  schema:name "A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors"@en ;
  schema:description "A phase 1/2 trial of Petosemtamab, Pembrolizumab, FOLFIRI in colorectal cancer and head and neck squamous cell carcinoma, run by Merus B.V., now recruiting."@en ;
  schema:url <https://onco.cc/trials/nct03526835/> ;
  schema:dateModified "2026-09-16"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT03526835> ;
  onco:status "recruiting" ;
  onco:tag "ctgov-ingest" ;
  onco:phase "1/2" ;
  schema:startDate "2018-05-02" ;
  onco:cancers <https://onco.cc/cancers/colorectal/>, <https://onco.cc/cancers/head-and-neck/> ;
  onco:technologies <https://onco.cc/technologies/bispecific-antibody/> ;
  onco:drugs <https://onco.cc/drugs/petosemtamab/>, <https://onco.cc/drugs/pembrolizumab/>, <https://onco.cc/drugs/folfiri/>, <https://onco.cc/drugs/folfox/> ;
  onco:companies <https://onco.cc/companies/genmab/> .